Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: AIDS Behav. 2020 May;24(5):1432–1442. doi: 10.1007/s10461-019-02707-1

Table 4:

Associations between male partner disclosure, engagement, and support with low ring adherence, measured by residual ring concentrations >22mg*

Model # Exposure # visits n (%) with low adherence Unadjusted Risk ratio 95% CI p Adjusted for age, site, and time in study Risk ratio 95% CI p
1 Primary partner knows about ring use

Yes 16,117 5,493 (34.1%) Ref Ref
No/not sure 4,582 1,630 (35.6%) 1.07 0.98 - 1.17 0.13 1.09 0.99 - 1.19 0.07

Primary partner attended clinic to date

No 18,471 6,372 (34.5%) Ref Ref
Yes 2,228 751 (33.7%) 0.90 0.79-1.02 0.09 0.88 0.77-1.00 0.06
Interaction: Disclosure x clinic attendance 1.12 0.82-1.55 0.47 1.12 0.81-1.55 0.51

2 Primary partner support^

Supportive 651 210 (32.3) Ref Ref
Not supportive 149 63 (42.3) 1.31 1.05-1.63 0.02 1.29 1.03-1.62 0.03
Unknown 160 44 (27.5) 0.85 0.65-1.12 0.26 0.87 0.66-1.15 0.32
*

Both models exclude visits with product hold or no primary partner reported.

^

Study exit visits only.